Skip to main content
Equibles
RPID logo

RPID · Rapid Micro Biosystems, Inc. · Metrics

Track RPID — free

Use RPID with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RPID.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.20 -0.01 (-0.83%) At close · Sep 10
Rebalance outlook locked
Market Cap
$60.69M
Shares
50.16M

RPID metrics

63 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.21
Market cap
$60.69M

Price action

20 metrics
Price change (1W)
-12.9%
Price change (30D)
-28.4%
Price change (3M)
-33.9%
Price change (6M)
-72.4%
Price change (YTD)
-58.3%
Price change (1Y)
-54.6%
Trailing year
Price change (5Y)
-94.2%
52-week high
$4.68
52-week low
$1.21
Change from 52-week high
-74.1%
Change from 52-week low
+0.0%
Annualized volatility
83.3%
Annualized volatility (3M)
67.6%
Beta
1.8
RSI (14D)
18.9
Price vs SMA 50
-32.5%
Price vs SMA 200
-55.5%
Avg volume (3M)
221,201
Relative volume
1.9
Average dollar volume
$388,807

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
50.16M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 58.0%
P / book
3.4
reciprocal yield 29.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-84.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 69.7%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 69.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
—
Operating margin
-141.5%
Trailing 12 months
Net margin
-145.6%
Gross profit (TTM)
—
Operating profit (TTM)
−$49.76M
Net income (TTM)
−$51.20M
Trailing 12 months
Diluted EPS (TTM)
$-1.10
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+10.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$35.18M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+8.3%
Year over year · more shares
Revenue CAGR (3Y)
+25.2%
Revenue CAGR (5Y)
+15.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-288.5%
Return on assets
-87.6%
Debt / equity
1.1
Current ratio
2.5
EBITDA (TTM)
−$46.78M
Free cash flow (TTM)
—
Quick ratio
1.5
Interest coverage
-21.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$14.69M
Total assets
$58.45M
Total debt
$19.14M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$40.06M
Capital expenditures (TTM)
$336,000
R&D (TTM)
$13.44M
SG&A (TTM)
—
Stock compensation (TTM)
$4.32M
R&D / revenue
38.2%
Stock compensation / revenue
12.3%

Ownership (13F)

3 metrics
13F filers
33
13F filer change QoQ
-13
Institutional ownership
34.7%

Short interest

3 metrics
Short interest
1.7%
Latest settlement · 4.5 days to cover
Days to cover
4.5d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1380106 CUSIP 75340L104 13F (30d) 25 filings 25 filers Visit website Investor relations